ALOX5 and breast cancer: Our research team demonstrated that BC and GP in combination (BC/GP, 7:3) might ameliorate cerebral ischemic injury by inhibiting the 5-LOX/cysteinyl leukotrienes (CysLTs) pathway [23, 24].